Article ; Online: Zinc-doped hydroxyapatite as a pH responsive drug delivery system for anticancer drug 6-mercaptopurine.
Journal of biomedical materials research. Part B, Applied biomaterials
2024 Volume 112, Issue 3, Page(s) e35395
Abstract: 6-Mercaptopurine (6MP) is commonly used in the treatment of acute lymphoblastic leukemia as an important agent in maintenance therapy. Despite its therapeutic benefits, 6MP has some limitations during therapy. Taking into account the disadvantages during ...
Abstract | 6-Mercaptopurine (6MP) is commonly used in the treatment of acute lymphoblastic leukemia as an important agent in maintenance therapy. Despite its therapeutic benefits, 6MP has some limitations during therapy. Taking into account the disadvantages during 6MP therapy, there is a great need to create an appropriate delivery system for this drug. 6MP contains in its structure nitrogen and sulfur atoms capable of forming coordination compounds with metal ions, for example zinc. Therefore, in this work, we prepared biocompatible hydroxyapatite (HAp) doped with zinc ions, and used it as a carrier for 6MP. Doped HAp has not been used as a carrier for this drug before. The work proved that the prepared carrier-drug system has a particle size of about 130 nm, which indicates its potential for intravenous delivery. In addition, in an acidic environment (imitating cancer cells), the carrier agglomerates allow targeted release of the drug. The drug is evenly distributed, which indicates that the doses released from it will always be comparable. The release of the drug in a neutral environment is long-lasting in controlled doses, whereas in an acidic environment it is immediate. The obtained results indicate the high potential of the material in both slow-release and cancer-targeted release of 6MP. |
---|---|
MeSH term(s) | Mercaptopurine/pharmacology ; Zinc/pharmacology ; Drug Delivery Systems ; Durapatite/pharmacology ; Antineoplastic Agents/pharmacology ; Ions ; Hydrogen-Ion Concentration |
Chemical Substances | Mercaptopurine (E7WED276I5) ; Zinc (J41CSQ7QDS) ; Durapatite (91D9GV0Z28) ; Antineoplastic Agents ; Ions |
Language | English |
Publishing date | 2024-03-04 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 2099992-6 |
ISSN | 1552-4981 ; 1552-4973 ; 0021-9304 |
ISSN (online) | 1552-4981 |
ISSN | 1552-4973 ; 0021-9304 |
DOI | 10.1002/jbm.b.35395 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6196: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.